AACR Cancer Progress Report 2023
Four in 10 cancers diagnosed each year in the United States are related to potentially preventable causes. Learn about cancer risk reduction and prevention.
Read the Report
Four in 10 cancers diagnosed each year in the United States are related to potentially preventable causes. Learn about cancer risk reduction and prevention.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreWhat Is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the ReportChildhood acute lymphoblastic leukemia (ALL) is the most common type of pediatric cancer. September is Childhood Cancer Awareness Month and Leukemia and Lymphoma Awareness Month.
Learn MoreDr. Luis Diaz: Marrying Cancer Genomics with Immunotherapy – “It worked better than our wildest dreams.”
Learn MoreResearchers have developed a vaccine that may improve the response to therapy in patients with multiple myeloma and help keep the cancer at bay by stimulating the body’s immune system.
Read Cancer DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowAACR members in good standing have priority access to the Annual Meeting housing site through Monday, September 25. Reserve your hotel accommodations now.
The AACR Cancer Progress Report 2023 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 54,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreA new wave of research-driven discoveries and technological innovations are delivering – and will propel additional – transformative advances to save more lives from cancer..
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now
